ask="51.50"
ask_size="100"
average_daily_volume="399850"
bid="46.61"
bid_size="200"
book_value="14.89"
change="-0.56"
change_from_200_day_moving_average="-3.22"
change_from_50_day_moving_average="-5.24"
change_from_52_week_high="-14.03"
change_From_52_week_low="18.94"
change_in_percent="-1.18%"
close="46.95"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.74"
eps_estimate_next_year="-3.15"
ex_dividend_date="N/A"
float_shares="24015000"
high="47.88"
high_52_weeks="60.98"
last_trade_date="1/18/2017"
last_trade_price="46.95"
last_trade_size="343"
last_trade_time="4:00pm"
low="45.69"
low_52_weeks="28.01"
market_capitalization="1.27B"
moving_average_200_day="50.17"
moving_average_50_day="52.19"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.17"
open="47.58"
pe_ratio="5.25"
peg_ratio="0.36"
percent_change_from_200_day_moving_average="-6.41%"
percent_change_from_50_day_moving_average="-10.05%"
percent_change_from_52_week_high="-23.01%"
percent_change_from_52_week_low="+67.62%"
previous_close="47.51"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.19"
price_per_sales="3.34"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.09"
stock_exchange="NMS"
symbol="FPRX"
volume="334255"
weeks_range_52="28.01 - 60.98"
